日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase II randomised study of magrolimab combined with bevacizumab-FOLFIRI in patients with previously treated advanced inoperable metastatic colorectal cancer

一项针对既往接受过治疗的晚期不可切除转移性结直肠癌患者的 II 期随机研究,评估了 magrolimab 联合贝伐单抗-FOLFIRI 方案的疗效。

Fakih, M; Gill, S; Sampat, K; Chan, D L; Fisher, G; Cruz-Correa, M; Lenz, H-J; Garcia-Alfonso, P; Forget, F; Lonardi, S; Krauss, J; Chen, E; Cubillo Gracian, A; Liu, Y; van Buuren, N; Shao, J; Dong, M; Chen, A; Tejani, M; Hecht, J R

Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study

在既往接受过治疗的微卫星不稳定性高/错配修复缺陷型转移性结直肠癌患者中,使用纳武利尤单抗联合瑞拉利单抗治疗:II期CheckMate 142研究

Overman, Michael J; Gelsomino, Fabio; Aglietta, Massimo; Wong, Mark; Limon Miron, Maria Luisa; Leonard, Gregory; García-Alfonso, Pilar; Hill, Andrew G; Cubillo Gracian, Antonio; Van Cutsem, Eric; El-Rayes, Bassel; McCraith, Stephen M; He, Beilei; Lei, Ming; Lonardi, Sara

Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial

纳武利尤单抗联合卡博替尼,加或不加伊匹木单抗治疗晚期肝细胞癌:CheckMate 040试验第6组队列的结果

Yau, Thomas; Zagonel, Vittorina; Santoro, Armando; Acosta-Rivera, Mirelis; Choo, Su Pin; Matilla, Ana; He, Aiwu Ruth; Cubillo Gracian, Antonio; El-Khoueiry, Anthony B; Sangro, Bruno; Eldawy, Tarek E; Bruix, Jordi; Frassineti, Giovanni Luca; Vaccaro, Gina M; Tschaika, Marina; Scheffold, Christian; Koopmans, Petra; Neely, Jaclyn; Piscaglia, Fabio

Recommendations on the use of azole antifungals in hematology-oncology patients

关于在血液肿瘤患者中使用唑类抗真菌药物的建议

Azanza, J R; Mensa, J; Barberán, J; Vázquez, L; Pérez de Oteyza, J; Kwon, M; Yáñez, L; Aguado, J M; Cubillo Gracian, A; Solano, C; Ruiz Camps, I; Fortún, J; Salavert Lletí, M; Gudiol, C; Olave Rubio, T; Solano, C; García-Vidal, C; Rovira Tarrats, M; Suárez-Lledó Grande, M; González-Sierra, P; Dueñas Gutiérrez, C

Analysis of origin, risk factors influencing COVID-19 cases in India and its prediction using ensemble learning

利用集成学习分析印度新冠肺炎病例的起源、风险因素及其预测

Rosas, Ivan O; Bräu, Norbert; Waters, Michael; Go, Ronaldo C; Hunter, Bradley D; Bhagani, Sanjay; Skiest, Daniel; Aziz, Mariam S; Cooper, Nichola; Douglas, Ivor S; Savic, Sinisa; Youngstein, Taryn; Del Sorbo, Lorenzo; Cubillo Gracian, Antonio; De La Zerda, David J; Ustianowski, Andrew; Bao, Min; Dimonaco, Sophie; Graham, Emily; Matharu, Balpreet; Spotswood, Helen; Tsai, Larry; Malhotra, Atul; Rajesh, N; Christodoss, Prasanna Ranjith

Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100

一项针对胃癌患者的III期临床试验:一线诱导化疗后使用阿维鲁单抗维持治疗与继续化疗的比较:JAVELIN Gastric 100研究结果

Moehler, Markus; Dvorkin, Mikhail; Boku, Narikazu; Özgüroğlu, Mustafa; Ryu, Min-Hee; Muntean, Alina S; Lonardi, Sara; Nechaeva, Marina; Bragagnoli, Arinilda C; Coşkun, Hasan S; Cubillo Gracian, Antonio; Takano, Toshimi; Wong, Rachel; Safran, Howard; Vaccaro, Gina M; Wainberg, Zev A; Silver, Matthew R; Xiong, Huiling; Hong, Janet; Taieb, Julien; Bang, Yung-Jue

A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer

一项针对转移性结直肠癌患者的 II 期随机研究,比较了维利帕尼联合 FOLFIRI 方案±贝伐单抗与安慰剂联合 FOLFIRI 方案±贝伐单抗的疗效。

Gorbunova, Vera; Beck, J Thaddeus; Hofheinz, Ralf-Dieter; Garcia-Alfonso, Pilar; Nechaeva, Marina; Cubillo Gracian, Antonio; Mangel, Laszlo; Elez Fernandez, Elena; Deming, Dustin A; Ramanathan, Ramesh K; Torres, Alison H; Sullivan, Danielle; Luo, Yan; Berlin, Jordan D